These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 21576273

  • 21. The I Ks Ion Channel Activator Mefenamic Acid Requires KCNE1 and Modulates Channel Gating in a Subunit-Dependent Manner.
    Wang Y, Eldstrom J, Fedida D.
    Mol Pharmacol; 2020 Feb; 97(2):132-144. PubMed ID: 31722973
    [Abstract] [Full Text] [Related]

  • 22. A kinetic study on the stereospecific inhibition of KCNQ1 and I(Ks) by the chromanol 293B.
    Seebohm G, Lerche C, Pusch M, Steinmeyer K, Brüggemann A, Busch AE.
    Br J Pharmacol; 2001 Dec; 134(8):1647-54. PubMed ID: 11739240
    [Abstract] [Full Text] [Related]

  • 23. Disruption of the K+ channel beta-subunit KCNE3 reveals an important role in intestinal and tracheal Cl- transport.
    Preston P, Wartosch L, Günzel D, Fromm M, Kongsuphol P, Ousingsawat J, Kunzelmann K, Barhanin J, Warth R, Jentsch TJ.
    J Biol Chem; 2010 Mar 05; 285(10):7165-75. PubMed ID: 20051516
    [Abstract] [Full Text] [Related]

  • 24. Characterization of chromanol 293B-induced block of the delayed-rectifier K+ current in heart-derived H9c2 cells.
    Lo YC, Yang SR, Huang MH, Liu YC, Wu SN.
    Life Sci; 2005 Apr 01; 76(20):2275-86. PubMed ID: 15748622
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Modulation of functional properties of KCNQ1 channel by association of KCNE1 and KCNE2.
    Toyoda F, Ueyama H, Ding WG, Matsuura H.
    Biochem Biophys Res Commun; 2006 Jun 09; 344(3):814-20. PubMed ID: 16631607
    [Abstract] [Full Text] [Related]

  • 29. Vascular effects of class-III antiarrhythmic drugs: chromanol 293B, but not dofetilide blocks the smooth muscle delayed rectifier K+ channel.
    Karle CA, Bauer A, Weretka S, Zitron E, Abushi A, Kreye VA, Schoels W.
    Basic Res Cardiol; 2002 Jan 09; 97(1):17-25. PubMed ID: 11998973
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Effects of I(Ks) channel inhibitors in insulin-secreting INS-1 cells.
    Ullrich S, Su J, Ranta F, Wittekindt OH, Ris F, Rösler M, Gerlach U, Heitzmann D, Warth R, Lang F.
    Pflugers Arch; 2005 Dec 09; 451(3):428-36. PubMed ID: 16133261
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Stoichiometry of the KCNQ1 - KCNE1 ion channel complex.
    Nakajo K, Ulbrich MH, Kubo Y, Isacoff EY.
    Proc Natl Acad Sci U S A; 2010 Nov 02; 107(44):18862-7. PubMed ID: 20962273
    [Abstract] [Full Text] [Related]

  • 37. The membrane protein KCNQ1 potassium ion channel: Functional diversity and current structural insights.
    Dixit G, Dabney-Smith C, Lorigan GA.
    Biochim Biophys Acta Biomembr; 2020 May 01; 1862(5):183148. PubMed ID: 31825788
    [Abstract] [Full Text] [Related]

  • 38. Deafness in LIMP2-deficient mice due to early loss of the potassium channel KCNQ1/KCNE1 in marginal cells of the stria vascularis.
    Knipper M, Claussen C, Rüttiger L, Zimmermann U, Lüllmann-Rauch R, Eskelinen EL, Schröder J, Schwake M, Saftig P.
    J Physiol; 2006 Oct 01; 576(Pt 1):73-86. PubMed ID: 16901941
    [Abstract] [Full Text] [Related]

  • 39. Modulation of Ca2+-activated Cl- secretion by basolateral K+ channels in human normal and cystic fibrosis airway epithelia.
    Mall M, Gonska T, Thomas J, Schreiber R, Seydewitz HH, Kuehr J, Brandis M, Kunzelmann K.
    Pediatr Res; 2003 Apr 01; 53(4):608-18. PubMed ID: 12612194
    [Abstract] [Full Text] [Related]

  • 40. A novel role of the antitumor agent tricyclodecan-9-yl-xanthogenate as an open channel blocker of KCNQ1/KCNE1.
    Wu M, Takemoto M, Luo H, Xu JJ, Lu MH, Kameyama M, Takumi T, Song WJ.
    Eur J Pharmacol; 2018 Apr 05; 824():99-107. PubMed ID: 29438706
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.